3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Large B-Cell, Diffuse
7
Prostatic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Melanoma
2
Down Syndrome
2
Carcinoma, Merkel Cell
2
Carcinoma, Basal Cell
2
Plasmablastic Lymphoma
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myeloid, Accelerated Phase
1
HTLV-I Infections
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Cisplatin
22
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Platinum
12
Radiotherapy, Intensity-Modulated
11
1,2-diaminocyclohexaneplatinum II citrate
11
Radiotherapy
10
Radiation
10
Carboplatin
9
Biopsy
5
pembrolizumab
4
Taxes
4
Surveys and Questionnaires
4
Paclitaxel
4
Nivolumab
4
Docetaxel
4
Chemoradiotherapy
4
Cetuximab
4
Fluorodeoxyglucose F18
3
(225)Ac-DOTA-c(RGDyK)
3
durvalumab
2
X-Rays
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Observation
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
prednylidene
×
90 days
×
Clear all
No trials found.